Actos (pioglitazone) reduces the risk of heart attack and stroke in some patients with type 2 diabetes
October 2005
New evidence shows that Actos (pioglitazone) reduces the risk of heart attack and stroke in some patients with type 2 diabetes.
We know that improving glycemic control reduces the risk of MICROvascular complications...retinopathy, nephropathy, neuropathy.
But there are questions about whether improving glycemic control reduces MACROvascular complications...heart attack and stroke.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive